MKDWELL Tech Inc. current report, Q3 FY2026

Business Context and Reporting Period

Company: MKDWELL Tech Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: September 11, 2026
Reporting Period: Month of September 2026
Principal Executive Office: Hsinchu Science Park, Taiwan

Key Financial Metrics

This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The document reports solely on the entry into a material definitive agreement.

Material Changes

On September 11, 2026, the Company entered into an At the Market Offering Agreement (the "Sales Agreement") with Maxim Group LLC. Key terms include:

  • Offering Program: Authorization to sell ordinary shares with an aggregate offering price of up to $100,000,000.
  • Sales Method: "At the market" offerings, potentially through The Nasdaq Capital Market, at the Company's sole discretion.
  • Placement Fees:
    • 3.0% on gross proceeds up to $10 million.
    • 2.75% on gross proceeds between $10 million and $20 million.
    • 2.5% on gross proceeds exceeding $20 million.
  • Expense Reimbursement: Up to $50,000 for legal fees and up to $5,000 per fiscal quarter for due diligence.

Guidance, Outlook, and Risks

Use of Proceeds: Net proceeds are intended for general corporate purposes, including working capital, capital expenditures, future acquisitions, and strategic investments. The Company currently has no specific plans or commitments regarding these expenditures.

Risks and Contingencies:

  • The Company is not obligated to sell any shares, and there is no guarantee that sales will be completed.
  • The offering may terminate upon the sale of all authorized shares or earlier termination of the agreement.
  • Sales are subject to market conditions and the Company's discretion regarding price, time, and size limits.

Investor Verification Checklist

  • Verify the current market price of MKDWELL Tech Inc. ordinary shares to assess potential dilution impact.
  • Review the full text of the Sales Agreement (Exhibit 1.1) for specific covenants and termination rights.
  • Monitor future filings for actual sales volumes and proceeds generated under the program.
  • Check the Company's authorized but unissued share count to confirm the maximum number of shares available for sale.